about
Selectins mediate small cell lung cancer systemic metastasisIdentification of the adult human hemangioblastCD34 modulates the trafficking behavior of hematopoietic cells in vivoMembrane-anchored peptide inhibits human immunodeficiency virus entry.Control of bone formation by the serpentine receptor Frizzled-9In-vivo RGB marking and multicolour single-cell tracking in the adult brainThe inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro.Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis.Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion.Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.Side effects of retroviral gene transfer into hematopoietic stem cells.Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleasesDenosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.CD133 marks a stem cell population that drives human primary myelofibrosis.Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs.mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable.Investigation of the Mesenchymal Stem Cell Compartment by Means of a Lentiviral Barcode Library.Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.Limitations and challenges of genetic barcode quantification.Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer.Microglia regulate hippocampal neurogenesis during chronic neurodegenerationDigital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation.Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins.Multiplexing clonality: combining RGB marking and genetic barcoding.Efficient lentiviral transduction and transgene expression in primary human B cells.Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood.Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis.A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.
P50
Q27314565-BAE1444F-C5E4-4F1B-B45E-7D4592F5F0C0Q28265904-6DBB380F-F234-4858-B342-9D943C15020AQ28315801-084CC7BC-3C68-4426-8D6F-FB4419BCE33BQ28354004-71024201-948A-4400-9C1D-7EDF23F4EE9EQ28587080-90BA6D21-BC98-4A57-9FFE-C110F96CC51EQ30610594-B037F4D8-08C4-46DF-BFA2-F90D02F8E08EQ32173527-2CACB45C-5E0A-4380-9A22-9EEA6C45CD8AQ33385308-A969C0FA-C2D1-45E8-A85E-A9462B52B29DQ33712953-FD765534-1FF6-44D7-81D5-1AFC4010A106Q33767496-DE4EA32A-327D-4F73-A6DC-9F7C0CCBF70EQ33907452-B1674D9D-97EC-4DA9-B7D1-42EB8D3702E6Q33908547-3C2B5C45-86D1-4E23-A753-A85818C35733Q33937526-1E62BA27-7AC5-4FD9-AADE-5F04C3B4DCC8Q34027421-D72A2E5F-BB9D-404C-BF10-727F9BD48963Q34168349-4109062C-50D7-4CB3-A7B1-A67102B1552FQ34200828-A4661327-A350-4D15-9596-A7C838837CBFQ34334341-349EA328-6BC6-48E1-BF08-6C5DE3BF2960Q35035023-626B50AA-B790-4700-AAAE-6288F21BC360Q35637501-56BA56C2-9624-48FF-95E4-B9F6B2256BE5Q35642820-D97BCA17-BBDE-4749-AE28-47BC325B6238Q35649591-9D1ABEFE-2A29-4EA1-88A5-F2C23ABB8C7EQ35669866-C08C744C-62CE-4D8F-A89C-01C09DBA2F09Q35742534-CD989F20-146B-485E-9DEB-9A2FBD0EDAE3Q35770689-96C00C5A-DC44-476F-A5C7-17675ED30DA6Q35828499-B233837F-621F-4360-8F13-FA52B9CB2DF2Q35929299-DAB4D4BA-C2F4-4A06-A2B5-D358EA04ADC5Q36049895-632C24DC-F1C0-4D51-A27C-BB0A7572FDE8Q36205499-CBA6548D-6D65-436D-B3B8-55FF5A94899FQ36296320-33366DAE-5B4F-4D72-8087-3B6FE9E17560Q36424249-D94C60B9-801B-4857-909D-72227CF6732CQ36925733-465FA3B9-53F7-4432-BAA8-61C0AAFFC770Q37003405-FA704A3F-FCB7-4B21-9E82-465112927192Q37286538-4F5A3A0B-A433-4D40-B370-C97D9393F2D3Q37687119-E341F1AE-5694-4D9E-ABB4-384B091A4244Q37701291-CA669403-85FE-43C0-95B3-FEA7F20971A3Q38456136-D0E8F25A-89B4-42ED-8904-7233AC9FD294Q38505890-C47C56A5-D902-4228-9FFB-53AEAA115ADDQ38508008-5B487536-03E1-47D5-B069-6E3D34F1DD1DQ38514169-8E41D3F4-EE60-4E8B-8287-52BE96CF83D5Q38626158-EC299288-D1C9-40D7-85D2-1B9440AAD6D3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Boris Fehse
@ast
Boris Fehse
@br
Boris Fehse
@co
Boris Fehse
@cs
Boris Fehse
@da
Boris Fehse
@de
Boris Fehse
@en
Boris Fehse
@es
Boris Fehse
@fr
Boris Fehse
@id
type
label
Boris Fehse
@ast
Boris Fehse
@br
Boris Fehse
@co
Boris Fehse
@cs
Boris Fehse
@da
Boris Fehse
@de
Boris Fehse
@en
Boris Fehse
@es
Boris Fehse
@fr
Boris Fehse
@id
prefLabel
Boris Fehse
@ast
Boris Fehse
@br
Boris Fehse
@co
Boris Fehse
@cs
Boris Fehse
@da
Boris Fehse
@de
Boris Fehse
@en
Boris Fehse
@es
Boris Fehse
@fr
Boris Fehse
@id
P214
P244
P106
P1153
56251332200
7003951856
P21
P214
P244
n2015181254
P2798
P31
P496
0000-0001-9780-7211
P735
P7859
lccn-n2015181254